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Dear Editor,
Escitalopram, S-isomer of sitalopram is well tolerated, rapid onset 
efficacy and used in the tratment of depression and other psychiatric 
disorders in elderly1-3. Escitalopram is highly serotonin specific and 
has minimal effect on the reuptake of other neurotransmitters4. 
Insomnia, headache, tremor, nausea, flushing, sweating, diarrhea, 
sexual dysfunction have been reported to be adverse drug reaction 
during escitalopram therapy3,5,6. In elderly patients, edema is an 
important health problem. Heart failure, renal failure, malabsorpsion, 
liver failure, allergic reactions, local inflammation and infections, 
burns, lymphatic obstruction increased capillary permeability, venous 
obstruction and drugs can cause peripheral edema7. Antihypertensive 
medications, nonsteroidal anti-inflammatory agents, calcium channel 
blockers, corticosteroids, hormones, antibiotics, beta blockers and 
direct vasodilators are drugs that often cause peripheral edema7,8. 
Edema has been reported rarely with psychiatric medications. Pre-
marketing trials have reported peripheral edema as an infrequent 
adverse event which occured less than 1/1009. To the best of our 
knowladge, there are two case reports that edema associated with 
escitalopram. First, bilateral ankle edema in 69 year-old female patient 
after one month therapy with escitalopram 30 mg per day, resolved 
within first week after discontinuation of the drug10. In second case, 
bilateral pedal edema associated with escitalopram 10 mg per day 
developed 9th day of the treatment and resolved within 10 days after 
discontinuation of the drug11. Here, we report a case of bilateral leg 
edema on the 7th day of the treatment with escitalopram 10 mg/day 
and resolved within 12 days after discontinuation of the drug. 
Case
A 71-year-old woman was presented with a three months history of 
lack of energy, loss of interest, hypersomnia, malaise and anxiety. We 
diagnosed major depression to the patient according to the DSM-IV 
criteria and we started escitalopram 10 mg/day as an antidepressant 
medication. She was admitted to dermatology policlinics with 
bilateral edema on shins on 7th day after escitalopram was started. On 
dermatological examination, there was swelling on the shins in both 
legs. Cellulite was not considered. There was no change of skin redness, 
ulceration and color. Results of renal function tests, thyroid function 
tests and liver function tests were within the normal limits. Blood 
electrolyte levels were normal. Echocardiogram and ECG findings 
were normal. There was no reason that could be found for edema. 
Escitalopram was reduced and stopped. After discontinuation of 
escitalopram, edema decreased. After 12 days, patient’s legs were back to 
normal. Naranjo Adverse Drug Reaction Probability Scale was evaluated 
as 7 points a probable adverse effect associated with escitalopram12.
Discussion
Edema has been reported during treatment with various 
antidepressants such as mirtazapine, trazodone, tranylcypromine, 
phenelzine and isocarboxazid13-15. In literature, edema associated with 
escitalopram reported in two cases10-11. In first case, bilateral ankle 
edema may be associated with high dosage of escitalopram (30 mg 
per day)9. Higher dosages up to 20 mg per day is not recommended 
by the pharmaceutical industry. In our case bilateral leg edema 
was developed in therapeutic doses. In first case with a 69-year-old 
depressed woman had been receiving atenolol and bromozepam for 
mild hypertension simultaneously with escitalopram10. In second 
case, 71 year-old patient with bilateral pedal edema had been 
receiving warfarin, bisoprolol and clonazepam simultaneously with 
escitalopram for atrial fibrillation and paroxysmal supraventricular 
tachcardia11. We know that drugs such as anxiolytics, antihypertensive 
drugs and beta blockers and comorbid diseases such as atrial 
fibrillation, hypertension and paroxysmal supraventricular tachcardia 
may have contributed to the development of peripheral edema 
in two cases reported in literature7. Therefore, these drugs may 
have contributed to the development of edema directly or via 
drug interaction in these cases. Unlike, there was no medication 
simultaneously with escitalopram and comorbid disease in our 
patient. Therefore, bilateral leg edema may be directly associated with 
escitalopram and no drug interactions was observed in our patient. 
The possible etiology of edema with escitalopram may be due to 
increase in vascular permeability8. It may be an idiosyncratically drug 
reaction because of the strong serotonergic effects of escitalopram11. 
Peripheral edema, a rare side effect due to escitalopram is 
reversible. Clinicians should be careful about this side effect because 
this side effect may occur at therapeutic doses and even if no 
medication and comorbid disease in patient’s history. 
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